On August 30, 2018 Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, reported that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 20TH Annual Global Investment Conference, being held in New York City on September 4-6, 2018 (Press release, Leap Therapeutics, AUG 30, 2018, View Source;p=RssLanding&cat=news&id=2365574 [SID1234529242]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Leap Presentation Details:
H.C. Wainwright 20th Annual Global Investment Conference
Date: Thursday, September 6, 2018
Time: 9:35 A.M.
The presentation will be webcast live and may be accessed on the Investors page of the company’s website at www.investors.leaptx.com, where a replay of the event will also be available for a limited time.